The Enterprise Value as of June 2026 (TTM) for Heron Therapeutics, Inc. (HRTX) is 178.71M

According to Heron Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 178.71M. This represents a change of -48.46% compared to the average of 346.76M of the last 4 quarters.

Heron Therapeutics, Inc. (HRTX) Historical Enterprise Value (quarterly & annually)

How has HRTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Heron Therapeutics, Inc. over the last ten years is 946.26M. The current 178.71M Enterprise Value has changed 1.79% with respect to the historical average. Over the past ten years (40 quarters), HRTX's Enterprise Value was at its highest in in the June 2018 quarter at 2.57B. The Enterprise Value was at its lowest in in the March 2026 quarter at 267.25M.

Heron Therapeutics, Inc. (HRTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Heron Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Heron Therapeutics, Inc. (HRTX) Average Enterprise Value

How has HRTX Enterprise Value performed in the past?

The current Enterprise Value of Heron Therapeutics, Inc. (HRTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Heron Therapeutics, Inc. (HRTX) Enterprise Value vs. Peers

How is HRTX’s Enterprise Value compared to its peers?

Heron Therapeutics, Inc.’s Enterprise Value is greater than Neonc Technologies Holdings, Inc. (95.18M), greater than Invivyd, Inc. (-73325330.00), greater than Protara Therapeutics, Inc. (138.82M), less than SELLAS Life Sciences Group, Inc. (1.01B), less than Genfit S.A. (513.33M), greater than MediWound Ltd. (117.94M), greater than Protalix BioTherapeutics, Inc. (135.16M), greater than Coherus Oncology, Inc. (110.51M), less than OmniAb, Inc. (260.96M), greater than Eupraxia Pharmaceuticals Inc. (160.77M),

Build a custom stock screener for Heron Therapeutics, Inc. (HRTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Heron Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Heron Therapeutics, Inc. (HRTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Heron Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.